Study suggests new treatment for diabetes

Diabetes treatment - Dr Keith Al-Hassani and Dr Ishant Khurana

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Melbourne researchers awaken key progenitor cells by DNA demethylation in diabetes study.

Type 2 diabetes is a serious condition that greatly impacts the health, wellbeing and lifespan of individuals across the globe. The human body’s ability to regenerate is largely limited as development genes are switched off by a process called DNA methylation. This is a process where methyl groups are written on DNA, and gene functioning is modified. This effectively silences the body’s highly-coveted progenitor cells, which in turn negatively impacts the pancreas’s ability to generate insulin producing β-cells.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Eleanor Garth

Editor

Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

With a keen interest in all things geroscience, Eleanor covers the biological mechanisms of aging, highlighting how interventions – from nutritional strategies to advanced therapeutics – can influence the aging process at a cellular level. She also investigates the broader implications of aging research, including the integration of longevity science into healthcare strategy and the expanding wellness economy. Her work (hopefully) provides insights into how these developments are shaping the emerging landscape of healthspan optimization and age-related innovation.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Oura spends $625m to put doctors behind its smart ring

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE